MLTX offering history
Every offering-related filing in MoonLake Immunotherapeutics’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 329 filings back to Aug 28, 2020.
| Date | Filing | What it means | |
|---|---|---|---|
| Aug 10, 2026 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Jun 24, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 22, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 5, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 11, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 31, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jun 29, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 27, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 26, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 11, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 9, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 4, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 1, 2023 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Mar 28, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 27, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 14, 2022 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Aug 12, 2022 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Aug 2, 2022 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Aug 2, 2022 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 26, 2022 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jul 15, 2022 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| May 2, 2022 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Apr 11, 2022 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 14, 2022 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Mar 8, 2022 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Feb 11, 2022 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Oct 4, 2021 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 22, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 21, 2020 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Oct 19, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 16, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Oct 14, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Oct 1, 2020 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
MLTX offering FAQ
When did MLTX last execute an offering?
Per SEC filings, MoonLake Immunotherapeutics's most recent priced offering document is a 424B5 filed 2026-06-24. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did MLTX last announce or register an offering?
The most recent registration is a S-3ASR filed 2026-08-10. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.
Free to use. No account, no card.